Crosstex buys ConFirm

HAUPPAUGE, New York--Crosstex International, a subsidiary of Cantel Medical Corp., has purchased the sterilization monitoring business of Colorado-based ConFirm Monitoring Systems.

To read more about Crosstex, go to Crosstex.

Crosstex, a leading global provider of infection prevention and control products, is a sales and technology leader
in sterilization pouches in the dental market. Crosstex’s flagship Sure-Check sterilization pouches have patent-pending Class 4 internal/external multi-variable indicators that validate all three criteria for instrument sterilization (time, temperature, and steam), as per ISO standards and CDC guidelines.

For more than 10 years, ConFirm has been a leading provider of biological monitoring services for sterilization
equipment in North America, conducting more than two million tests annually. The company offers a mail-in service and in-office spore test kits for health-care professionals to verify the performance of their sterilizers in accordance with industry guidelines for daily or weekly testing.

“This represents a marriage of two best-of-breed technologies and two market leaders,” said Andrew Whitehead,
Crosstex senior vice president of sales and marketing. “Sure-Check pouches provide the most advanced chemical
monitoring to confirm each sterilization cycle. When combined with ConFirm’s biological monitoring for daily or weekly testing of the sterilizer, health-care professionals will have the ultimate in sterilization assurance for their practice.”

According to Gary Steinberg, CEO of Crosstex, “ConFirm is an ideal addition to our sterilization product portfolio.
Given that the sterilizer is a critical component of infection control in every dental office and most health-care
facilities, we want to provide the most effective tools to ensure it is functioning properly.”

For more information, contact Crosstex at (631) 582-6777 or visit www.crosstex.com.

To comment on this subject, go to community.pennwelldentalgroup.com/.